These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20584517)

  • 1. Two-year outcome of treatment with central stimulant medication in adult attention-deficit/hyperactivity disorder: a prospective study.
    Bejerot S; Rydén EM; Arlinde CM
    J Clin Psychiatry; 2010 Dec; 71(12):1590-7. PubMed ID: 20584517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulant treatment of adult attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Psychiatr Clin North Am; 2004 Jun; 27(2):361-72. PubMed ID: 15064002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.
    Poulton A
    Expert Rev Neurother; 2006 Apr; 6(4):551-61. PubMed ID: 16623654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric outpatient department].
    Kooij JJ; Aeckerlin LP; Buitelaar JK
    Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1498-501. PubMed ID: 11512422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of stimulants on a clinical measure of attention in children with ADHD.
    Gardner BK; Sheppard DM; Efron D
    Child Neuropsychol; 2008 Mar; 14(2):171-86. PubMed ID: 17852126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulant treatment over five years: adherence, effectiveness, and adverse effects.
    Charach A; Ickowicz A; Schachar R
    J Am Acad Child Adolesc Psychiatry; 2004 May; 43(5):559-67. PubMed ID: 15100562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone-to-methylphenidate switch reaction in children: three cases.
    Sabuncuoglu O
    J Psychopharmacol; 2007 Mar; 21(2):216-9. PubMed ID: 17329303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J
    J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Attention-deficit/hyperactivity disorder. Clinical and treatment aspects].
    Diaconu G; Grigore I; Burlea M
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):656-62. PubMed ID: 20191811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming the barriers to effective treatment for attention-deficit/hyperactivity disorder: a neuro-educational approach.
    Monastra VJ
    Int J Psychophysiol; 2005 Oct; 58(1):71-80. PubMed ID: 15927296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The psychopharmacology of the comorbid disorders associated with attention deficit hyperactivity disorder].
    de la Osa-Langreo A; Mulas F; Téllez de Meneses M; Gandía R; Mattos L
    Rev Neurol; 2007 Mar; 44 Suppl 2():S31-5. PubMed ID: 17347942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled study of autonomic nervous system function in adults with attention-deficit/hyperactivity disorder treated with stimulant medications: results of a pilot study.
    Schubiner H; Hassunizadeh B; Kaczynski R
    J Atten Disord; 2006 Nov; 10(2):205-11. PubMed ID: 17085631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.
    Pliszka SR
    J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperactive behavior in adults; possibly attention deficit/hyperactivity disorder (ADHD)].
    Weisfelt M; Schrier AC; de Leeuw MC
    Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1481-4. PubMed ID: 11512417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder.
    Chacko A; Pelham WE; Gnagy EM; Greiner A; Vallano G; Bukstein O; Rancurello M
    J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):249-57. PubMed ID: 15725969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.